The role of skeletal muscle in amyotrophic lateral sclerosis

Brain Pathology

Volumn 26, Issue 2, 2016, Pages 227-236

  Loeffler, Jean Philippe ^a   Picchiarelli, Gina ^a   Dupuis, Luc ^a   Gonzalez De Aguilar, Jose Luis ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

amyotrophic lateral sclerosis; Cu Zn superoxide dismutase; energy metabolism; mitochondria; oxidative stress; skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANDROSTANOLONE; BECLIN 1; CASPASE 3; CATALASE; CREATINE; CYCLIN DEPENDENT KINASE 5; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOLYTIC ENZYME; HISTONE DEACETYLASE 4; MITOCHONDRIAL DNA; MYOGENIN; NANDROLONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR PAX7; UNCOUPLING PROTEIN 1;

AEROBIC METABOLISM; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; BIOENERGY; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FAST MUSCLE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GASTROCNEMIUS MUSCLE; GENE OVEREXPRESSION; GENE TRANSFER; HINDLIMB MUSCLE; HUMAN; MITOCHONDRIAL BIOGENESIS; MOTONEURON; MOTOR UNIT; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CONTRACTION; MUSCLE EXERCISE; MUSCLE INNERVATION; MUSCLE MASS; MUSCLE STRENGTH; NERVE FIBER REGENERATION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NEUROPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OOCYTE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PATHOLOGY; PROTEOMICS; RESPIRATORY CHAIN; SKELETAL MUSCLE; SURVIVAL; SYNAPSE; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; DRUG EFFECTS; PATHOPHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; MUSCLE, SKELETAL;

EID: 84961785320     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12350     Document Type: Conference Paper

References (135)

1. Al-Sarraj S, King A, Cleveland M, Pradat PF, Corse A, Rothstein JD, et al, (2014) Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathol Commun 2: 165.
2. Artuso L, Zoccolella S, Favia P, Amati A, Capozzo R, Logroscino G, et al, (2013) Mitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 14: 261-266.
3. Atkin JD, Scott RL, West JM, Lopes E, Quah AK, Cheema SS, (2005) Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul Disord 15: 377-388.
4. Barber SC, Shaw PJ, (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48: 629-641.
5. Bhattacharya A, Wei R, Hamilton RT, Chaudhuri AR, (2014) Neuronal cells but not muscle cells are resistant to oxidative stress mediated protein misfolding and cell death: role of molecular chaperones. Biochem Biophys Res Commun 446: 1250-1254.
6. Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ, (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125: 777-794.
7. Bogaert E, d'Ydewalle C, Van Den Bosch L., Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target (2010) CNS Neurol Disord Drug Targets 9: 297-304.
8. Bordet T, Lesbordes JC, Rouhani S, Castelnau-Ptakhine L, Schmalbruch H, Haase G, Kahn A, (2001) Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum Mol Genet 10: 1925-1933.
9. Bowerman M, Salsac C, Coque E, Eiselt É, Deschaumes RG, Brodovitch A, et al, (2015) Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet 24: 3440-3456.
10. Bruneteau G, Bauché S, Gonzalez de Aguilar JL, Brochier G, Mandjee N, Tanguy ML, et al, (2015) Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 2: 362-372.
11. Bruneteau G, Simonet T, Bauché S, Mandjee N, Malfatti E, Girard E, et al, (2013) Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 136: 2359-2368.
12. Capitanio D, Vasso M, Ratti A, Grignaschi G, Volta M, Moriggi M, et al, (2012) Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model. Antioxid Redox Signal 17: 1333-1350.
13. Cappello V, Vezzoli E, Righi M, Fossati M, Mariotti R, Crespi A, et al, (2012) Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS. Mol Cell Neurosci 51: 12-21.
14. Chen D, Wang Y, Chin ER, (2015) Activation of the endoplasmic reticulum stress response in skeletal muscle of G93A∗SOD1 amyotrophic lateral sclerosis mice. Front Cell Neurosci 9: 170.
15. Chin ER, Chen D, Bobyk KD, Mázala DA, (2014) Perturbations in intracellular Ca2+ handling in skeletal muscle in the G93A∗SOD1 mouse model of amyotrophic lateral sclerosis. Am J Physiol Cell Physiol 307: C1031-C1038.
16. Chung MJ, Suh YL, (2002) Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol 26: 3-7.
17. Cohen TJ, Barrientos T, Hartman ZC, Garvey SM, Cox GA, Yao TP, (2009) The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity. FASEB J 23: 99-106.
18. Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, Ly L, et al, (2014) Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82: 295-307.
19. Cozzolino M, Carrì MT, (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97: 54-66.
20. Crippa V, Boncoraglio A, Galbiati M, Aggarwal T, Rusmini P, Giorgetti E, et al, (2013) Differential autophagy power in the spinal cord and muscle of transgenic ALS mice. Front Cell Neurosci 7: 234.
21. Crippa V, Galbiati M, Boncoraglio A, Rusmini P, Onesto E, Giorgetti E, et al, (2013) Motoneuronal and muscle-selective removal of ALS-related misfolded proteins. Biochem Soc Trans 41: 1598-1604.
22. Crugnola V, Lamperti C, Lucchini V, Ronchi D, Peverelli L, Prelle A, et al, (2010) Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol 67: 849-854.
23. Da Cruz S, Parone PA, Lopes VS, Lillo C, McAlonis-Downes M, Lee SK, et al, (2012) Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15: 778-786.
24. David G, Nguyen K, Barrett EF, (2007) Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice. Exp Neurol 204: 411-420.
25. de Oliveira GP, Maximino JR, Maschietto M, Zanoteli E, Puga RD, Lima L, et al, (2014) Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model. Cell Mol Neurobiol 34: 451-462.
26. De Winter F, Vo T, Stam FJ, Wisman LA, Bär PR, Niclou SP, et al, (2006) The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 32: 102-117.
27. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al, (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256.
28. Dentel C, Palamiuc L, Henriques A, Lannes B, Spreux-Varoquaux O, Gutknecht L, et al, (2013) Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Brain 136: 483-493.
29. Derave W, Van Den Bosch L, Lemmens G, Eijnde BO, Robberecht W, Hespel P, (2003) Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol Dis 13: 264-272.
30. Dobrowolny G, Aucello M, Molinaro M, Musarò A, (2008) Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model. Neurol Res 30: 131-136.
31. Dobrowolny G, Aucello M, Musarò A, (2011) Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation. Skelet Muscle 1: 3.
32. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, et al, (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8: 425-436.
33. Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, et al, (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168: 193-199.
34. Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F, Oudart H, et al, (2009) Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 4: e5390.
35. Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL, Loeffler JP, (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 101: 11159-11164.
36. Echaniz-Laguna A, Zoll J, Ponsot E, N'guessan B, Tranchant C, Loeffler JP, Lampert E, (2006) Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol 198: 25-30.
37. Echaniz-Laguna A, Zoll J, Ribera F, Tranchant C, Warter JM, Lonsdorfer J, Lampert E, (2002) Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol 52: 623-627.
38. Evans RM, Harridge SD, Velloso CP, Yang SY, Goldspink G, Orrell RW, (2010) Investigation of MGF mRNA expression in patients with amyotrophic lateral sclerosis using parallel in vivo and in vitro approaches. Amyotroph Lateral Scler 11: 172-177.
39. Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, René F, Hocquette JF, et al, (2007) Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 48: 1571-1580.
40. Fischer-Hayes LR, Brotherton T, Glass JD, (2013) Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp Neurol 246: 6-13.
41. Galbiati M, Onesto E, Zito A, Crippa V, Rusmini P, Mariotti R, et al, (2012) The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis. Pharmacol Res 65: 221-230.
42. Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, et al, (2007) Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J Neurosci 27: 13173-13180.
43. Gordon T, Tyreman N, Li S, Putman CT, Hegedus J, (2010) Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 37: 412-422.
44. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al, (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772-1775.
45. Halon M, Kaczor JJ, Ziolkowski W, Flis DJ, Borkowska A, Popowska U, et al, (2014) Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation. Free Radic Res 48: 1363-1370.
46. Halter B, Gonzalez de Aguilar JL, Rene F, Petri S, Fricker B, Echaniz-Laguna A, et al, (2010) Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 48: 915-923.
47. Han SM, El Oussini H, Scekic-Zahirovic J, Vibbert J, Cottee P, Prasain JK, et al, (2013) VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans. PLoS Genet 9: e1003738.
48. Hegedus J, Putman CT, Gordon T, (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28: 154-164.
49. Hegedus J, Putman CT, Gordon T, (2009) Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender. Muscle Nerve 39: 318-327.
50. Holzbaur EL, Howland DS, Weber N, Wallace K, She Y, Kwak S, et al, (2006) Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis 23: 697-707.
51. Hussain G, Schmitt F, Henriques A, Lequeu T, Rene F, Bindler F, et al, Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS One 8: e64525.
52. Hwee DT, Kennedy A, Ryans J, Russell AJ, Jia Z, Hinken AC, et al, (2014) Fast skeletal muscle troponin activator tirasemtiv increases muscle function and performance in the B6SJL-SOD1G93A ALS mouse model. PLoS One 9: e96921.
53. Johnson AE, Shu H, Hauswirth AG, Tong A, Davis GW, (2015) VCP-dependent muscle degeneration is linked to defects in a dynamic tubular lysosomal network in vivo. Elife 4.
54. Jokic N, Gonzalez de Aguilar JL, Dimou L, Lin S, Fergani A, Ruegg MA, et al, (2006) The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep 7: 1162-1167.
55. Jokic N, Gonzalez de Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, Muller A, et al, (2005) Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 57: 553-556.
56. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al, (2011) Amyotrophic lateral sclerosis. Lancet 377: 942-955.
57. Kira Y, Nishikawa M, Ochi A, Sato E, Inoue M, (2006) L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis. Brain Res 1070: 206-214.
58. Kliem MA, Heeke BL, Franz CK, Radovitskiy I, Raore B, Barrow E, et al, (2011) Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats. Amyotroph Lateral Scler 12: 331-339.
59. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, et al, (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5: 347-350.
60. Kraft AD, Resch JM, Johnson DA, Johnson JA, (2007) Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp Neurol 207: 107-117.
61. Krakora D, Mulcrone P, Meyer M, Lewis C, Bernau K, Gowing G, et al, (2013) Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther 21: 1602-1610.
62. Krasnianski A, Deschauer M, Neudecker S, Gellerich FN, Müller T, et al, (2005) Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain 128: 1870-1876.
63. Küst BM, Copray JC, Brouwer N, Troost D, Boddeke HW, (2002) Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 177: 419-427.
64. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al, (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
65. Leclerc N, Ribera F, Zoll J, Warter JM, Poindron P, Lampert E, Borg J, (2001) Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice. Neuromuscul Disord 11: 722-727.
66. Léger B, Vergani L, Sorarù G, Hespel P, Derave W, Gobelet C, et al, (2006) Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20: 583-585.
67. Li W, Brakefield D, Pan Y, Hunter D, Myckatyn TM, Parsadanian A, (2007) Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 203: 457-471.
68. Ling SC, Polymenidou M, Cleveland DW, (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416-438.
69. Lu YY, Wang LJ, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, et al, (2003) Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport. Neurosci Res 45: 33-40.
70. Lunetta C, Serafini M, Prelle A, Magni P, Dozio E, Ruscica M, et al, (2012) Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve 45: 200-208.
71. Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, Zhou J, (2013) Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS One 8: e82112.
72. Mahoney DJ, Kaczor JJ, Bourgeois J, Yasuda N, Tarnopolsky MA, (2006) Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle Nerve 33: 809-816.
73. Manzano R, Toivonen JM, Calvo AC, Oliván S, Zaragoza P, Rodellar C, et al, (2013) Altered in vitro proliferation of mouse SOD1-G93A skeletal muscle satellite cells. Neurodegener Dis 11: 153-164.
74. Manzano R, Toivonen JM, Oliván S, Calvo AC, Moreno-Igoa M, Muñoz MJ, et al, (2011) Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 8: 386-396.
75. Marcuzzo S, Zucca I, Mastropietro A, de Rosbo NK, Cavalcante P, Tartari S, et al, (2011) Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study. Exp Neurol 231: 30-37.
76. Mattson MP, Cutler RG, Camandola S, (2007) Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med 9: 17-20.
77. Messi ML, Clark HM, Prevette DM, Oppenheim RW, Delbono O, (2007) The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS. Exp Neurol 207: 52-63.
78. Miller TM, Kaspar BK, Kops GJ, Yamanaka K, Christian LJ, Gage FH, Cleveland DW, (2005) Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol 57: 773-776.
79. Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, Arnson H, et al, (2006) Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103: 19546-19551.
80. Mohajeri MH, Figlewicz DA, Bohn MC, (1999) Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 10: 1853-1866.
81. Moloney EB, de Winter F, Verhaagen J, (2014) ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci 8: 252.
82. Morrison BM, Lachey JL, Warsing LC, Ting BL, Pullen AE, Underwood KW, et al, (2009) A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 217: 258-268.
83. Nagahara Y, Shimazawa M, Tanaka H, Ono Y, Noda Y, Ohuchi K, et al, (2015) Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Neurosci Res 93: 1552-1566.
84. Nonneman A, Robberecht W, Van Den Bosch L, (2014) The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis. Neurodegener Dis Manag 4: 223-239.
85. Oliván S, Calvo AC, Gasco S, Muñoz MJ, Zaragoza P, Osta R, (2015) Time-Point Dependent Activation of Autophagy and the UPS in SOD1G93A Mice Skeletal Muscle. PLoS One 10: e0134830.
86. Oliván S, Martínez-Beamonte R, Calvo AC, Surra JC, Manzano R, Arnal C, et al, (2014) Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. J Nutr Biochem 25: 885-892.
87. Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, et al, (2015) A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med 7: 526-546.
88. Palma E, Inghilleri M, Conti L, Deflorio C, Frasca V, Manteca A, et al, (2011) Physiological characterization of human muscle acetylcholine receptors from ALS patients. Proc Natl Acad Sci USA 108: 20184-20188.
89. Park KH, Franciosi S, Leavitt BR, (2013) Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model. Nat Commun 4: 2906.
90. Park KH, Vincent I, (2008) Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Biochim Biophys Acta 1782: 462-468.
91. Pastor D, Viso-León MC, Botella-López A, Jaramillo-Merchan J, Moraleda JM, Jones J, Martínez S, (2013) Bone marrow transplantation in hindlimb muscles of motoneuron degenerative mice reduces neuronal death and improves motor function. Stem Cells Dev 22: 1633-1644.
92. Peled-Kamar M, Lotem J, Wirguin I, Weiner L, Hermalin A, Groner Y, (1997) Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase. Proc Natl Acad Sci USA 94: 3883-3887.
93. Philips T, Robberecht W, (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10: 253-263.
94. Pradat PF, Barani A, Wanschitz J, Dubourg O, Lombès A, Bigot A, et al, (2011) Abnormalities of satellite cells function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12: 264-271.
95. Ramírez-Jarquín UN, Lazo-Gómez R, Tovar-Y-Romo LB, Tapia R, (2014) Spinal inhibitory circuits and their role in motor neuron degeneration. Neuropharmacology 82: 101-107.
96. Renton AE, Chiò A, Traynor BJ, (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17: 17-23.
97. Riddoch-Contreras J, Yang SY, Dick JR, Goldspink G, Orrell RW, Greensmith L, (2009) Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improvesmuscle function in SOD1(G93A) mice. Exp Neurol 215: 281-289.
98. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW, (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92: 689-693.
99. Rocha MC, Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA, (2013) Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One 8: e73846.
100. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A Donaldson, et al, (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
101. Russell AP, Wada S, Vergani L, Hock MB, Lamon S, Léger B, et al, (2013) Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 49: 107-117.
102. Ryan TE, Erickson ML, Verma A, Chavez J, Rivner MH, Mccully KK, (2014) Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis. Muscle Nerve 50: 767-774.
103. Scaramozza A, Marchese V, Papa V, Salaroli R, Sorarù G, Angelini C, Cenacchi G, (2014) Skeletal muscle satellite cells in amyotrophic lateral sclerosis. Ultrastruct Pathol 38: 295-302.
104. Sharp PS, Dick JR, Greensmith L, (2005) The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 130: 897-910.
105. Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, et al, (2012) Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13: 430-438.
106. Siciliano G, D'Avino C, Del Corona A, Barsacchi R, Kusmic C, Rocchi A, et al, (2002) Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 3: 57-62.
107. Siciliano G, Pastorini E, Pasquali L, Manca ML, Iudice A, Murri L, (2001) Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci 191: 61-65.
108. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al, (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672.
109. Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, Elliott JL, (2013) TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS One 8: e71793.
110. Staunton L, Jockusch H, Ohlendieck K, (2011) Proteomic analysis of muscle affected by motor neuron degeneration: the wobbler mouse model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun 406: 595-600.
111. Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, et al, (2008) Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 16: 2002-2010.
112. Suzuki N, Mizuno H, Warita H, Takeda S, Itoyama Y, Aoki M, (2010) Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis. J Neurol Sci 294: 95-101.
113. Thau N, Knippenberg S, Körner S, Rath KJ, Dengler R, Petri S, (2012) Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J Neuropathol Exp Neurol 71: 1064-1074.
114. Toivonen JM, Manzano R, Oliván S, Zaragoza P, García-Redondo A, Osta R, (2014) MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One 9: e89065.
115. Tokutake Y, Yamada K, Ohata M, Obayashi Y, Tsuchiya M, Yonekura S, (2015) ALS-linked P56S-VAPB mutation impairs the formation of multinuclear myotube in C2C12 cells. Int J Mol Sci 16: 18628-18641.
116. Turner BJ, Lopes EC, Cheema SS, (2003) Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 350: 132-136.
117. Valdez G, Heyer MP, Feng G, Sanes JR, (2014) The role of muscle microRNAs in repairing the neuromuscular junction. PLoS One 9: e93140.
118. Van Langenhove T, van der Zee J, Van Broeckhoven C, (2012) The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med 44: 817-828.
119. Vargas MR, Burton NC, Kutzke J, Gan L, Johnson DA, Schäfer M, et al, (2013) Absence of Nrf2 or its selective overexpression in neurons and muscle does not affect survival in ALS-linked mutant hSOD1 mouse models. PLoS One 8: e56625.
120. Vargas MR, Johnson JA, (2010) Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics 7: 471-481.
121. Vergouts M, Marinangeli C, Ingelbrecht C, Genard G, Schakman O, Sternotte A, et al, (2015) Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease. Metab Brain Dis 30: 1369-1377.
122. Vielhaber S, Kunz D, Winkler K, Wiedemann FR, Kirches E, Feistner H, et al, (2000) Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123: 1339-1348.
123. Vielhaber S, Winkler K, Kirches E, Kunz D, Büchner M, Feistner H, et al, (1999) Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 169: 133-139.
124. Wang LJ, Lu YY, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, et al, (2002) Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22: 6920-6928.
125. Wei R, Bhattacharya A, Chintalaramulu N, Jernigan AL, Liu Y, Van Remmen H, Chaudhuri AR, (2012) Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS. Biochem Biophys Res Commun 417: 1275-1279.
126. Wei R, Bhattacharya A, Hamilton RT, Jernigan AL, Chaudhuri AR, (2013) Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network. Biochem Biophys Res Commun 438: 218-223.
127. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS, (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156: 65-72.
128. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, et al, (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326: 1549-1554.
129. Wong M, Martin LJ, (2010) Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 19: 2284-2302.
130. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al, (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
131. Xiao Y, Ma C, Yi J, Wu S, Luo G, Xu X, et al, (2015) Suppressed autophagy flux in skeletal muscle of an amyotrophic lateral sclerosis mouse model during disease progression. Physiol Rep 3. pii: e12271.
132. Yamamoto M, Kobayashi Y, Li M, Niwa H, Mitsuma N, Ito Y, et al, (2001) In vivo gene electroporation of glial cell line-derived neurotrophic factor (GDNF) into skeletal muscle of SOD1 mutant mice. Neurochem Res 26: 1201-1207.
133. Yin F, Ye F, Tan L, Liu K, Xuan Z, Zhang J, et al, (2012) Alterations of signaling pathways in muscle tissues of patients with amyotrophic lateral sclerosis. Muscle Nerve 46: 861-870.
134. Yoo YE, Ko CP, (2012) Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS One 7: e37258.
135. Zhou J, Yi J, Fu R, Liu E, Siddique T, Ríos E, Deng HX, (2010) Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem 285: 705-712.